UNIVERSAL HEALTH SERVICES INC (UHS): Entry into a Material Definitive Agreement
UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 d177070dex11.htm EX-1.1 EX-1.1 Exhibit 1.1 UNIVERSAL HEALTH SERVICES, INC. $600,000,000 5.500% Senior Secured Notes due 2031 $500,000,000 6.000% Senior Secured Notes due 2036 Underwriting Agreement August 11, 2026 J.P. Morgan Securities LLC BofA Securities, Inc. Truist S
How this was made
The 30-second read
Why it matters
Traders may reassess UHS credit risk and capital structure based on the maturity ladder (2031 and 2036), secured lien coverage, and the stated repayment plan for September 2026 obligations.
Market read
A fresh SEC filing discloses a new secured debt issuance and refinancing use of proceeds, which can move credit-sensitive positioning and debt-equity sentiment.
What to watch
Collateral scope, excluded assets, and any incremental covenant or refinancing risk details in the full exhibits could materially affect credit risk beyond the headline amounts.
Background
The 8-K reports entry into a material definitive agreement for UHS to issue $1.1B of senior secured notes under an indenture framework, with proceeds earmarked for refinancing existing 2026 secured notes and revolver balances.
Ticker impact
UHS entered a material definitive agreement to issue $600M 5.500% secured notes due 2031 and $500M 6.000% secured notes due 2036.
Near-term trading likely modest, with focus on leverage/refinancing optics and secured-collateral terms rather than immediate earnings impact.
This is a primary SEC 8-K disclosure of capital structure actions, but the excerpt does not include pricing, covenants beyond collateral description, or guidance, limiting precision on magnitude and direction.
Market effects
Hospital operators may see read-across on secured debt appetite and refinancing conditions, but this is company-specific debt issuance.
No clear regional demand signal beyond US credit markets.
Limited, as the transaction is US-denominated secured notes with domestic underwriting.
Counterpoint
Secured debt issuance can be viewed as a leverage-supporting move rather than balance-sheet improvement, especially if proceeds also fund general corporate purposes.
Key entities
- issuerUniversal Health Services, Inc.
Subject of the 8-K, proposing and agreeing to issue $600M 5.500% notes due 2031 and $500M 6.000% notes due 2036.
- underwriterJ.P. Morgan Securities LLC
One of the representatives/underwriters in the underwriting agreement for the notes.
- trusteeU.S. Bank Trust Company, National Association
Trustee under the indenture for the notes.
- collateral agentJPMorgan Chase Bank, N.A.
Collateral agent under the indenture framework.
